The U.S. Food and Drug Administration expanded the use of Rhythm Pharmaceuticals’  therapy for a rare form of obesity ​caused ...

The neurodegenerative condition chronic traumatic encephalopathy appears to be driven by damage to the blood-brain barrier ...

Traumatic brain injuries are quickly emerging as the signature wound of the U.S. war with Iran so far, echoing a pattern of ...

New guidelines emphasize selective imaging, cautious surgical decision-making, and more in penetrating traumatic brain injury management.

Tiny plastic particles may be quietly threatening brain health. New research suggests microplastics—now widely found in food, ...

Miss Jamaica Gabrielle Henry has been released from the hospital nearly four months after suffering a serious fall during the Miss Universe preliminary competition in November 2025. Henry remains ...

Research, led by teams at Trinity College Dublin and the FutureNeuro Research Ireland Center, has pinpointed the mechanism ...

A widely used drug combination in anti-aging research may have a far more complicated effect on the brain than previously recognized. In mice, the treatment appeared to disrupt the cells responsible ...

President Catherine Connolly is set to officially open a new exhibition in Wexford town consisting of artworks that have been ...

More than half a million Coloradans are living with a disability tied to a brain injury, according to the state's Department ...

President Catherine Connolly is set to officially open a new exhibition in Wexford town consisting of artworks that have been ...

Rhythm Pharmaceuticals is switching up the tempo for its melanocortin-4 receptor (MC4R) agonist Imcivree. | The new FDA nod makes Rhythm Pharma's Imcivree the first approved drug for acquired ...